Article
Generation of two human induced pluripotent stem cell lines from fibroblasts of Parkinson's disease patients carrying the ILE368ASN mutation in PINK1 (LCSBi002) and the R275W mutation in Parkin (LCSBI004).
Stem cell research - 1 May 2022
Novak Gabriela, Finkbeiner Steven, Skibinski Gaia, Bernini Michela, Donato Cristina, Skupin Alexander
Abstract excerpt
Mutations in PINK1 and Parkin are two of the main causes of recessive early-onset Parkinson's disease (PD). We generated human induced pluripotent stem cells (hiPSCs) from fibroblasts of a 64-year-old male patient with a homozygous ILE368ASN mutation in PINK1, who experienced disease onset at 33 years, and from fibroblasts of a 61-year-old female patient heterozygous for the R275W mutation in Parkin, who...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
